Dec 27, 2004Successfully close 2nd closing of series D equity finance
In December, 2004, Carna Biosciences has successfully closed 2nd closing of series D equity finance, which increased the company's capital to 731.7 million yen.
The newly issued shares were allocated to CrystalGenomics, Inc..
Nov 26, 2004Successfully close series D equity finance
In November, 2004, Carna Biosciences has successfully closed series D equity finance, which increased the company's capital to 681.7 million yen.
Oct 6, 2004Partnering with Fujirebio Inc. for collaborative research and development
Carna Biosciences and Fujirebio Inc. have agreed on collaborative research and development on monoclonal antibody for kinase, kinase measurement reagent and protein chip.
Jun 9, 2004Collaborative research with CrystalGenomics, Inc., Korea
Carna Biosciences and CrystalGenomics, Inc. have agreed on collaborative research on the discovery of drug candidate compounds.
Feb 10, 2004Collaborative support services to pharmaceutical companies with Itochu Corporation
Itochu Corporation aims to be the total solution provider for drug discovery and has agreed to support and invest in Carna Biosciences.
Feb 2, 2004Carna Bioscience has successfully closed series C finance
In December, 2003, Carna Biosciences has successfully closed series C finance, which increased the company's capital to 269.2 million yen. The newly issued shares were allocated to Itochu Corporation and investment funds managed by CSK Venture Capital Co., Ltd., Bio-Sight Capital Co., Ltd., Japan Asia Investment Co., Ltd., and NIF Ventures Co., Ltd.